Portfolio
3
companies
Atom
Atom operates as a digital app-based retail bank providing mortgages and savings products.
Genomics
Genomics builds precision healthcare tools using large-scale genetic information to prevent common diseases and cancers.
MoA Technology
MoA Technology develops next-generation herbicides to combat global weed resistance.
The Series C round was co-led by Oxford Science Enterprises and Supernova Invest to support product development.
"When we helped spin Moa out from the University of Oxford’s Plant Sciences Department in 2017, we saw that its technology platform had a unique and important approach to address the market’s need for herbicides capable of breaking weed resistance,"
The funding round was led by F-Prime Capital and Foresight Partners to support risk estimation technology and workforce expansion.
"Our vision is that in 10 to 15 years, genetic information will be ubiquitous in healthcare systems"
The funding follows a £75m raise in February and will support ongoing growth and retail lending.
"I’m delighted that the bank’s continued success means that BBVA, Toscafund and Infinity Investment Partners have added to their stake in Atom, and taken new capital investment during 2022 to over £100m. Our prudent, secured lending model, backed by award winning retail savings allows us to make the very most of capital to support income growth and boost customer numbers. This will remain our focus."
